NCT05386550 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 85
- group Id
- BG002
- value
- 166
- units
- Participants
- groups
- description
- Participants received 3 cycles of oral solution of Xevinapant at a dose of 200 milligrams per day (mg/day) once daily from Day 1 to 14, per 3-week cycle in combination with 66 Gray (Gy) of intensity modulated radiation therapy (IMRT) in 33 fractions, 2 Gy/fraction, 5 days/week followed by 3 cycles of monotherapy of Xevinapant at a dose of 200 mg/day from Day 1 to 14, per 3-week cycle (Each cycle is of 3 weeks).
- id
- BG000
- title
- Xevinapant + IMRT
- description
- Participants received 3 cycles of oral solution of placebo matched to Xevinapant once daily from Day 1 to 14 per 3-week cycle in combination with with 66 Gray (Gy) of intensity modulated radiation therapy (IMRT) in 33 fractions, 2 Gy/fraction, 5 days/week followed by 3 cycles of monotherapy of placebo matched to Xevinapant from Day 1 to 14, per 3-week cycle (Each cycle is of 3 weeks).
- id
- BG001
- title
- Placebo + IMRT
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.89
- value
- 69
- group Id
- BG001
- spread
- 9.61
- value
- 69
- group Id
- BG002
- spread
- 9.72
- value
- 69
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 39
- title
- Female
- measurements
- group Id
- BG000
- value
- 63
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 127
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 18
- title
- Ethnicity-Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 61
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 124
- title
- Ethnicity-Not Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 23
- title
- Ethnicity-Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Ethnicity-Unknown or Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Race-American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 45
- group Id
- BG002
- value
- 85
- title
- Race-Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Race-Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Race-More than one race
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 23
- title
- Race-Unknown or Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 55
- title
- Race-White
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 85
- group Id
- BG002
- value
- 166
- units
- Participants
- groups
- description
- Participants received 3 cycles of oral solution of Xevinapant at a dose of 200 milligrams per day (mg/day) once daily from Day 1 to 14, per 3-week cycle in combination with 66 Gray (Gy) of intensity modulated radiation therapy (IMRT) in 33 fractions, 2 Gy/fraction, 5 days/week followed by 3 cycles of monotherapy of Xevinapant at a dose of 200 mg/day from Day 1 to 14, per 3-week cycle (Each cycle is of 3 weeks).
- id
- BG000
- title
- Xevinapant + IMRT
- description
- Participants received 3 cycles of oral solution of placebo matched to Xevinapant once daily from Day 1 to 14 per 3-week cycle in combination with with 66 Gray (Gy) of intensity modulated radiation therapy (IMRT) in 33 fractions, 2 Gy/fraction, 5 days/week followed by 3 cycles of monotherapy of placebo matched to Xevinapant from Day 1 to 14, per 3-week cycle (Each cycle is of 3 weeks).
- id
- BG001
- title
- Placebo + IMRT
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.89
- value
- 69
- group Id
- BG001
- spread
- 9.61
- value
- 69
- group Id
- BG002
- spread
- 9.72
- value
- 69
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 39
- title
- Female
- measurements
- group Id
- BG000
- value
- 63
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 127
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 18
- title
- Ethnicity-Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 61
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 124
- title
- Ethnicity-Not Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 23
- title
- Ethnicity-Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Ethnicity-Unknown or Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Race-American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 45
- group Id
- BG002
- value
- 85
- title
- Race-Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Race-Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Race-More than one race
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 23
- title
- Race-Unknown or Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 55
- title
- Race-White
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle